KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Operating Leases: 2019-2023

Historic Operating Leases for Rigel Pharmaceuticals (RIGL) over the last 5 years, with Dec 2023 value amounting to $285,000.

  • Rigel Pharmaceuticals' Operating Leases was N/A to $556,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $556,000, marking a year-over-year change of. This contributed to the annual value of $285,000 for FY2023, which is 70.68% down from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported Operating Leases of $285,000 as of FY2023, which was down 70.68% from $972,000 recorded in FY2022.
  • Rigel Pharmaceuticals' 5-year Operating Leases high stood at $19.3 million for FY2020, and its period low was $285,000 during FY2023.
  • Its 3-year average for Operating Leases is $672,000, with a median of $759,000 in 2021.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Operating Leases crashed by 96.07% in 2021, and later grew by 28.06% in 2022.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Operating Leases stood at $19.2 million in 2019, then increased by 0.36% to $19.3 million in 2020, then plummeted by 96.07% to $759,000 in 2021, then climbed by 28.06% to $972,000 in 2022, then slumped by 70.68% to $285,000 in 2023.